1. Home
  2. AXIL vs NOTV Comparison

AXIL vs NOTV Comparison

Compare AXIL & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXIL Brands Inc.

AXIL

AXIL Brands Inc.

HOLD

Current Price

$8.14

Market Cap

32.4M

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.68

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXIL
NOTV
Founded
2015
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
29.9M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
AXIL
NOTV
Price
$8.14
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
1.5M
1.6M
Earning Date
01-07-2026
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$27,262,468.00
$513,024,000.00
Revenue This Year
N/A
$6.26
Revenue Next Year
N/A
$45.49
P/E Ratio
$59.54
N/A
Revenue Growth
0.07
4.54
52 Week Low
$3.75
$0.66
52 Week High
$10.75
$6.48

Technical Indicators

Market Signals
Indicator
AXIL
NOTV
Relative Strength Index (RSI) 72.31 30.65
Support Level $4.93 $0.79
Resistance Level $9.11 $0.86
Average True Range (ATR) 0.60 0.07
MACD 0.41 -0.00
Stochastic Oscillator 66.60 6.69

Price Performance

Historical Comparison
AXIL
NOTV

About AXIL AXIL Brands Inc.

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: